Association Between Mental Health Disorders and Sexual Dysfunction in Patients Suffering from Rheumatic Diseases

Abstract

Introduction Sexual functioning may be notoriously affected in patients suffering from rheumatic diseases, yet the extent to which physical and/or psychological factors contribute to sexual dysfunction in this particular group of patients remains underinvestigated. Aim This cross-sectional study aimed at investigating whether an association exists between psychological status (anxiety, depression) and sexual dysfunction, independently of other physical factors, in patients with rheumatic disorders. Methods A total of 509 consecutive rheumatologic patients, aged 54.7 ± 14.2 years, 423 female and 86 male, were studied. Female and male sexual function was evaluated with the Female Sexual Dysfunction Index (FSFI) and the International Index of Erectile Function (IIEF) questionnaire, respectively. The Hamilton Anxiety Scale and the Zung Self-Rating Depression Scale were used to detect presence of anxiety and depression, respectively. Main Outcome Measures Sexual dysfunction affected 69.9%, anxiety 37.5%, and depression 22% of our patients. Results A strong and negative correlation was found between anxiety and both FSFI (r = −0.169, P < 0.001) and IIEF score (r = −0.304, P = 0.004). Similarly, depressive symptomatology was strongly and negatively correlated with both FSFI (r = −0.178, P < 0.001) and IIEF score (r = −0.222, P = 0.04). In the logistic regression analysis, apart from increasing age and female sex, depression (P = 0.027) and anxiety (P = 0.049) were identified as the only predictors of sexual dysfunction, even after adjustment for a variety of physical factors. Conclusions Mental distress and sexual dysfunction are extremely common in rheumatologic patients. Sexual dysfunction is significantly associated with anxiety and depression in both men and women and may be independently predicted by their presence in this group of patients. Physicians dealing with rheumatologic patients should be aware of these results and incorporate screening and treatment of the above comorbidities in the global assessment of their patients, in order to alleviate the disease-emerging mental and physical burden and improve their quality of life.

How predictable is the erectile function of patients with epilepsy?

“…The same association has also been reported worldwide in patients with chronic renal failure [34], rheumatic diseases [35], and cardiac diseases [36]. Duncan et al [31] reported that interictal depression significantly affects the sexual desire in male patients with epilepsy, but, interestingly, they did not find a linear relationship between depression and erectile dysfunction.…”

“…Taken together, these results suggest that free testosterone levels may not be a globally useful predictor for erectile dysfunction determined by the IIEF in patients with nonneurologic diseases or epilepsy or in the community examined. Although depressive symptoms emerge as a putative biomarker for erectile dysfunction [34][35][36], the present experimental design and those of previous studies do not allow a cause-and-effect relationship to be established between depressive symptoms and erectile dysfunction. It is also not possible to determine if they are a biomarker of other nonidentified variables.…”

Sexual functioning and its correlates in premenopausal married Indian women with systemic lupus erythematosus

“…Psychiatric comorbidities also contribute to sexual dysfunction. Anyfanti et al studied the association between psychological factors and sexual function in rheumatic diseases and found a strong negative correlation between depression and anxiety and sexual function . In a study done by Morales et al, depression had a significant negative impact on sexual function .…”

The impact of systemic lupus erythematosus on women's sexual functioning

“…Previous studies have found that sexual function is significantly related to depression in female SLE patients [6,7,9,17] and depression affects about 40% of SLE patients, [18] so the clinical staff can improve patient's sexual function by improving the depressive state. Recent studies have shown that impairment of the normal structure and function of microglia, caused by autoimmune diseases, can result in depression and associated impairments in neuroplasticity and neurogenesis [19] and interferon-α-induced activation of microglia was particularly relevant to depressive-like behavior.…”